Cascinu S, Cordella L, ferro E et al
Key Takeaway: Don't chase instant results
And for those successfully using a currently available GLP-1 with success, there is no clinical reason to switch to retatrutide via a clinical trial right now
However, this approval was intended for adults with: A BMI 30 kg/m, or BMI 27 kg/m with at least one weight-related condition (e.g., hypertension, dyslipidemia, T2DM)
A Pharmacy Compounding Advisory Committee discussion was scheduled for 23 July 2026, after this articles review date
"In general, patients should avoid added sugar and processed food or what we may know as 'junk food' as much as possible," Dr